CASE HISTORY: Eastern Pharmaceutical Company
APPLICATION: Treatment of High-Strength Organic and Fermentation Wastes

Challenge
A pharmaceutical manufacturing facility in the US was starting up a new fermentation process that produced a wastewater with a flow of 100,000 gallons/day with a COD of approximately 40,000 mg/L. The facility desired to implement treatment without triggering off-site sludge disposal problems. The facility also desired to implement treatment that prevented off-site release of target compounds that were manufactured at the plant.

Solution
PMC BioTec performed bench work and other feasibility analyses prior to implementing AFC treatment of target wastes.

Bottom Line
• System has been in operation over two years

• AFC system cost was almost $7 million less than the next lowest alternative

• Off-site disposal of organic sludge has been virtually eliminated

• There is no discharge of GMOs (genetically modified organisms) or EDCs (endocrine disrupter compounds)